NCT01391962 2026-02-02Sunitinib or Cediranib for Alveolar Soft Part SarcomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed34 enrolled 22 charts
NCT00001337 2025-06-22Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's LymphomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed348 enrolled 15 charts